The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranson, T.
Right arrow Articles by Di Santo, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranson, T.
Right arrow Articles by Di Santo, J. P.
The Journal of Immunology, 2005, 175: 1137-1144.
Copyright © 2005 by The American Association of Immunologists

Invariant V{alpha}14+ NKT Cells Participate in the Early Response to Enteric Listeria monocytogenes Infection1

Thomas Ranson2,*, Søren Bregenholt2,3,*, Agnes Lehuen{dagger}, Olivier Gaillot{ddagger}, Maria C. Leite-de-Moraes§, André Herbelin§, Patrick Berche{ddagger} and James P. Di Santo4,*

* Unité des Cytokines et Développement Lymphoïde, Institut National de la Santé et de la Recherche Médicale Unité 668, Institut Pasteur, Paris, France;{dagger} Institut National de la Santé et de la Recherche Médicale Unité 561, Hopital Cochin-Saint Vincent de Paul, Paris, France;{ddagger} Laboratoire de Microbiologie, Institut National de la Santé et de la Recherche Médicale Unité 411, Faculté de Médecine Necker-Enfants Malades, Paris, France; and§ Centre National de la Recherche Scientifique Unité Mixte Recherche 8147, Paris V, Institut de Recherche Necker-Enfants Malades, Paris, France


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Invariant V{alpha}14+ NKT cells are a specialized CD1-reactive T cell subset implicated in innate and adaptive immunity. We assessed whether V{alpha}14+ NKT cells participated in the immune response against enteric Listeria monocytogenes infection in vivo. Using CD1d tetramers loaded with the synthetic lipid {alpha}-galactosylceramide (CD1d/{alpha}GC), we found that splenic and hepatic V{alpha}14+ NKT cells in C57BL/6 mice were early producers of IFN-{gamma} (but not IL-4) after L. monocytogenes infection. Adoptive transfer of V{alpha}14+ NKT cells derived from TCR{alpha}° V{alpha}14-J{alpha}18 transgenic (TCR{alpha}°V{alpha}14Tg) mice into alymphoid Rag°{gamma}c° mice demonstrated that V{alpha}14+ NKT cells were capable of providing early protection against enteric L. monocytogenes infection with systemic production of IFN-{gamma} and reduction of the bacterial burden in the liver and spleen. Rechallenge experiments demonstrated that previously immunized wild-type and J{alpha}18° mice, but not TCR{alpha}° or TCR{alpha}°V{alpha}14Tg mice, were able to mount adaptive responses to L. monocytogenes. These data demonstrate that V{alpha}14+ NKT cells are able to participate in the early response against enteric L. monocytogenes through amplification of IFN-{gamma} production, but are not essential for, nor capable of, mediating memory responses required to sterilize the host.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The primary control of infection by the intracellular pathogen Listeria monocytogenes relies on the ability of the host to mount an efficient Th1-like immune response (reviewed in Ref. 1). Production of IFN-{gamma} in the early phases of infection is essential to enhance IL-12 production and activate bactericidal mechanisms in macrophages (2, 3). NK cells have been identified as a source of early IFN-{gamma} production (4). Thus, SCID mice (T, B, NK+) are able to control primary L. monocytogenes infection in an IFN-{gamma}-dependent manner. Eventually SCID mice succumb to chronic listeriosis, demonstrating that NK cells alone are unable to fully protect the host against L. monocytogenes (5, 6). Instead, sterilizing immunity relies on the generation of cytotoxic CD8+ T cells which clear infected macrophages and hepatocytes and thereby eliminate the bacteria (reviewed in Refs. 1 and 7). The participation of other cell types has been described in the protection against L. monocytogenes. Several studies have defined a role for CD4+ T cells in both primary and secondary L. monocytogenes infection (8, 9). In addition, {gamma}{delta} T cells play a role in the defense against L. monocytogenes, since they are able to control primary infections in the absence of {alpha}{beta} TCR cells. However, {gamma}{delta} TCR cells are not able to mediate sterilizing immunity after infection (10).

NKT cells constitute a heterogeneous subset of T cells expressing both NK and T cell surface markers. One well-characterized NKT subset includes a thymus-derived population expressing a canonical V{alpha}14-J{alpha}18 TCR {alpha}-chain associated with a limited set of TCR{beta} subfamilies (reviewed in Ref. 11). These invariant V{alpha}14+ NKT cells, which are either CD4+ or CD4CD8 double negative, are selected on the nonclassical MHC class I molecule CD1. V{alpha}14+ NKT cells recognize an endogenous lysosomal glycosphingolipid, isoglobotrihexosylceramide (12), and when activated through their TCR or by soluble factors (such as IL-12) can produce both IFN-{gamma} and IL-4 (13, 14). Moreover, V{alpha}14+ NKT cells have been shown to transactivate B, T, and NK cells in vivo (15, 16). Along these lines, V{alpha}14+ NKT cells may act as sentinels to integrate initial signals following immune stimulation and thereby serve to orient subsequent immune responses.

V{alpha}14+ NKT have been implicated in a number of immune-mediated pathologies including graft-vs-host disease, autoimmune hepatitis, and in fetal loss (17, 18, 19). In addition, a disease-controlling role for NKT cells has been shown in V{alpha}14-J{alpha}18 transgenic (Tg)5 nonobese diabetic mice (20). V{alpha}14+ NKT cells may participate in antitumor responses by counteracting invasion and metastasis (reviewed in Ref. 21). Finally, a role for V{alpha}14+ NKT cells has been proposed for protection against parasites (Toxoplasma gondii, Plasmodium yoelii, and Plasmodium berghei) and intracellular pathogens (mycobacteria and L. monocytogenes) (reviewed in Ref. 22). V{alpha}14+ NKT cells could provide a protective role via IFN-{gamma} in sustaining Th1 responses (23). Alternatively, IL-4 production from V{alpha}14+ NKT cells could either have a deleterious role by deviating Th1 responses toward Th2 or act as an amplifier of Th2 responses in the context of extracellular parasites (24, 25). The precise role of V{alpha}14+ NKT cells in infection immunity is clearly not defined and could vary depending on the pathogen.

Concerning L. monocytogenes, previous studies have demonstrated that NKT-deficient mice can resist infection by L. monocytogenes similar to wild-type mice (8, 26), excluding an essential role for these cells in antilisterial immunity. In contrast, Kaufmann and coworkers found that NKT cells are selectively depleted from the liver of L. monocytogenes-infected mice and that treatment of infected mice with CD1-specific Abs ameliorated the antilisterial response via increased IFN-{gamma}, TNF-{alpha}, and IL-12 production (27, 28). This group proposed that NKT cells could play a negative role in the immunity against intracellular bacteria, possibly through production of TGF-{beta} (28). Considering these contradictory findings, we decided to re-examine the role for V{alpha}14+ NKT cells in the antilisterial response. Using several approaches in wild-type, Ja18°, and V{alpha}14 transgenic mice, we demonstrate that invariant V{alpha}14+ NKT cells clearly contribute to the pro-Th1 response following infection with L. monocytogenes but are not essential for or capable of mediating memory responses to this pathogen.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Mice

Rag° and Rag°{gamma}c° mice (29) were from the 10th backcross to the C57BL/6 background. TCR{alpha}° mice and V{alpha}14-J{alpha}18Tg on the TCR{alpha}-deficient C57BL/6 background (TCR{alpha}°V{alpha}14Tg) mice (20) as well as J{alpha}18° mice (30) have been previously described. C57BL/6 mice were purchased at IFFA-CREDO. Mice were housed at the Institut Pasteur (Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 668) and at Necker Hospital (INSERM Unité 411). All animal studies were evaluated and approved by a local institutional review board.

Abs and reagents

Abs were obtained from BD Pharmingen and were used as FITC, PE, biotin, and allophycocyanin conjugates. Biotinylated Abs were revealed with FITC-, PE (Caltag Laboratories) or PerCP-conjugated streptavidin (BD Pharmingen). Anti-CD19 microbeads and LS+ magnetic separation columns were obtained from Miltenyi Biotec. RPMI 1640, FCS, and antibiotics were purchased from Invitrogen Life Technologies. Percoll was purchased from Pharmacia. Brain-heart infusion medium (BHI) was obtained from Acumedia

Preparation of bacterial strains

Listeria monocytogenes (strain LO28) (31), was grown to exponential phase in BHI medium and harvested in the exponential growth phase, washed, and stored at –80°C in aliquots of 109 bacteria/ml in PBS.

Isolation of lymphoid cells

For isolation of lymphoid cells from peripheral lymphoid organs, mice were sacrificed and the mesenteric lymph node (mLN), spleen, and liver were removed. Single-cell suspensions were generated from mLN and spleen by teasing the organs through a metal mesh followed by erythrocyte lysis. Single-cell suspensions were generated from liver by teasing the organs through a metal mesh followed by centrifugation on a Percoll gradient (40/80%) and erythrocyte lysis.

Cell sorting and adoptive transfer into Rag°{gamma}c° mice

For electronic cell sorting, single-cell suspensions were generated from the mLN of TCR{alpha}°V{alpha}14Tg mice. Following erythrocyte lysis, lymph nodes cells were depleted of B cells using MACS anti-CD19 microbeads and LS columns according to the manufacturer’s instructions. Subsequently, the cells were incubated with biotinylated anti-CD5 mAb, PE, anti-CD8{alpha} mAb and allophycocyanin anti-NK1.1 mAb as described below. Biotinylated Ab was revealed by incubation with FITC-streptavidin. NKT cells were sorted as NK1.1+/CD8{alpha}/CD5+ cells using a MoFlo cell sorter (DakoCytomation). Post-sort analysis confirmed that these cells were >98% NKT cells and contained <0.4% contaminating NK cells. Nonirradiated Rag°{gamma}c° mice (3–6 wk of age) were transplanted i.v. with 5 x 105 purified NK1.1+ T cells 4 days before infection.

Infection and determination of CFU

For intragastric (i.g.) infection with 5 x 108 L. monocytogenes strain LO28, groups of mice were gavaged i.g. using an 18-gauge dumb-end feeding needle. For rechallenge experiments, mice were injected i.v. in the lateral tail vein with 2 x 106 bacteria.

At the indicated time points after infection, mice were sacrificed and the livers and spleens were aseptically removed. Homogenates of liver and spleen were prepared by grinding organs in sterile PBS with a motorized Teflon pestle. Bacterial CFU were enumerated by plating organ homogenates in 10-fold, serial dilutions on BHI agar plates. After incubation at 35°C for 36–48 h, the bacterial colonies were counted.

Flow cytometry

For surface Ab staining, cells were washed twice in PBS supplemented with 1% BSA (PBS-BSA), incubated on ice for 30 min with Abs, and subsequently washed twice in PBS-BSA before analysis. When appropriate, cells were incubated with biotin-conjugated Abs, washed three times, and then incubated for 30 min with the relevant streptavidin conjugate and then washed three times before analysis. Samples were analyzed using a FACSCalibur flow cytometer (BD Biosciences) and the data were analyzed using CellQuest software (BD Biosciences).

For intracellular cytokine detection, total cell suspensions were incubated for 1 h in RPMI 1640/5% FCS containing brefeldin A (10 µg/ml) to block cytokine secretion. Surface-stained cells (TCR{beta}+, tetramer+) were fixed for 1 h in PBS containing 2% paraformaldehyde, and intracellular cytokines were detected using a PE-conjugated IFN-{gamma} (XMG1.2) or control rat IgG1 (R3-34) mAbs in PBS containing 0.5% saponin.

Tetramer staining

Single-cell suspensions were stained for 20 min on ice with {alpha}-galactosylceramide ({alpha}-GC)-loaded allophycocyanin-conjugated CD1d tetramers (derived from mCD1d/{beta}2-microglobulin expression vector as described in Ref. 32). Cells were then washed twice with ice-cold PBS-BSA and subsequent Ab surface staining with FITC anti-TCR{beta} mAb and PE anti-NK1.1 mAb was performed as described above. Nonspecific binding was controlled by staining using CD1d tetramers without {alpha}-GC (data not shown).

ELISA

Serum was obtained (days 0 and 3 postinfection) and the concentrations of IFN-{gamma} were determined using a specific sandwich ELISA kit (Genzyme) according to the manufacturer’s instructions.

Statistics

Statistical significance was evaluated using the Mann-Whitney U test. Values of p < 0.05 were considered to be significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
V{alpha}14+ NKT cells participate directly in the antilisterial response in vivo

We used several independent and complementary approaches to assess the role of V{alpha}14+ NKT cells in antilisterial immunity. We first used CD1d tetramers loaded with the synthetic lipid {alpha}-GC to follow V{alpha}14+ NKT cell activation and cytokine production after i.g. L. monocytogenes infection of wild-type mice. Uninfected C57BL/6 mice harbored a population of CD1d/{alpha}-GC-reactive T cells which, on a percentage basis, were more abundant in the liver (6 ± 1.2%) than in the spleen (0.5 ± 0.1%; Fig. 1A and data not shown). These cells were mainly NK1.1+ and did not constitutively synthesize IFN-{gamma} (Fig. 1, B and C). As early as 24 h after i.g. infection with L. monocytogenes, invariant V{alpha}14+ NKT cells became activated and began to produce IFN-{gamma} (Fig. 1B), but not IL-4 (data not shown). It should be emphasized that the protocol used for ex vivo analysis of cytokine production by V{alpha}14+ NKT cells did not involve a TCR restimulation in vitro. By day 2 after L. monocytogenes infection, about one-half of the CD1d tetramer-reactive T cells in the liver and spleen were active in IFN-{gamma} production, and this fraction persisted at day 3 after infection (Fig. 1B and data not shown). Interestingly, the percentage of CD1d tetramer-reactive T cells decreased by days 2 and 3 after infection, which was correlated with a decreased density of NK1.1 expression (Fig. 1, A and C), although CD1d tetramer staining was still clearly observed. This "loss" of V{alpha}14+ NKT cells likely corresponds to a partial down-modulation of TCR and NK1.1 expression rather than an actual disappearance of the cells. These results clearly demonstrate the participation of NKT cells in response to L. monocytogenes via IFN-{gamma} production, a cytokine required for the control of this pathogen.



View larger version (44K):
[in this window]
[in a new window]
 
FIGURE 1. NKT cells participate in vivo in the early response to L. monocytogenes. Naive C57BL/6 mice were infected i.g. with 5 x 108 L. monocytogenes strain LO28 and invariant V{alpha}14+ NKT cells were analyzed using CD1d tetramers loaded with {alpha}-GC. A, Regions define the mean and SD of percentages of tetramer+ T cells in the liver of mice at indicated days after infection. B, Corresponding IFN-{gamma} production by hepatic CD1d-reactive T cells in C57BL/6 mice after L. monocytogenes infection. Bars indicate percentages of IFN-{gamma}-positive cells compared with staining with isotype control Abs. C, NK1.1 vs IFN-{gamma} expression on tetramer+ T cells in the liver of control and infected mice.

 
V{alpha}14+ NKT cells transctivate NK cells for IFN-{gamma} production after Listeria infection in vivo

Since V{alpha}14+ NKT cells have been demonstrated to transactivate {gamma}{delta} T cells, NK cells, and CD8 {alpha}{beta} T cells after TCR stimulation (15, 16), we asked whether this transactivation also occurred after infection by L. monocytogenes. We therefore analyzed the kinetics of NK cell IFN-{gamma} production in L. monocytogenes-infected C57BL/6 mice compared with V{alpha}14+ NKT cell-deficient J{alpha}18° mice (Fig. 2 and Table I). NK cells in the liver and spleen of uninfected wild-type mice did not constitutively produce IFN-{gamma}, but became IFN-{gamma}+ by day 1 after infection and continued to synthesize this cytokine throughout the time period analyzed (Table I). The peak of IFN-{gamma} production by NK cells was day 2 after L. monocytogenes infection and paralleled the kinetics of the response of the invariant V{alpha}14+ NKT cells (Fig. 1). In contrast, the kinetics of IFN-{gamma} production by NK cells in J{alpha}18° mice was clearly different. Production of IFN-{gamma} by NK cells in J{alpha}18° mice was significantly delayed in comparison to wild-type mice (no evidence for production at day 1 and peak production at day 3) and overall percentages of IFN-{gamma}+ NK cells were reduced (Table I). These results suggest that V{alpha}14+ NKT cells may be involved in amplifying the IFN-{gamma} production capacity of NK cells after L. monocytogenes infection.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 2. IFN-{gamma} production by NK cells after L. monocytogenes infection is decreased in the absence of V{alpha}14+ NKT cells. C57BL/6 or Ja18° mice were infected i.g. with 5 x 108 L. monocytogenes strain LO28, and IFN-{gamma} expression by gated splenic NK cells (NK1.1+, CD3) was analyzed at the indicated time after infection. Percentages of IFN-{gamma}-positive cells as compared with staining with isotype control Abs are indicated.

 

View this table:
[in this window]
[in a new window]
 
Table I. IFN-{gamma} production by NK cells following oral infection with L. monocytogenes

 
Antilisterial responses in V{alpha}14 NKT cell-deficient mice

We next asked whether V{alpha}14+ NKT cells were essential for immunity against L. monocytogenes. Previous studies have attempted to address this question using mice deficient in CD1 (26); however, since CD1° mice are also unable to select non-V{alpha}14 CD1d-reactive T cells (reviewed in Ref. 11), the unique roles for V{alpha}14+ NKT cells were not unambiguously defined. We therefore infected J{alpha}18° mice which have a selective deficiency in V{alpha}14+ NKT cells (30). Both wild-type and J{alpha}18° mice were able to control the initial infection (Fig. 3A), whereas alymphoid Rag°{gamma}c° mice were highly susceptible as previously described (33). In recall experiments, previously immunized wild-type and J{alpha}18° mice were protected against lethal challenge (106 bacteria i.v.), whereas naive wild-type mice succumbed rapidly to infection (Fig. 3B). These results demonstrate that V{alpha}14+ NKT cells are not essential for innate and adaptive responses to L. monocytogenes, despite their capacity to respond to this pathogen.



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 3. Role of invariant V{alpha}14+ NKT cells in primary and recall responses to L. monocytogenes infection. A, Survival of control C57BL/6 (•), J{alpha}18-deficient (J{alpha}18°, {blacksquare}), and alymphoid Rag°{gamma}c° mice ({circ}) to an i.g. infection of 5 x 108 L. monocytogenes strain LO28. B, Mice were immunized by i.g. infection as above and after 6 wk were rechallenged i.v. with a lethal dose (2 x 106) of L. monocytogenes strain LO28. Survival of immunized C57BL/6 (•), immunized J{alpha}18-deficient (J{alpha}18°, {blacksquare}), and naive C57BL/6 mice ({circ}) are shown. Experiments involved groups of four to six mice per genotype and were at least repeated twice.

 
Antilisterial responses in V{alpha}14 NKT cell Tg mice

We used mice harboring a productively rearranged TCR V{alpha}14-J{alpha}18 transgene on the TCR{alpha}-deficient background (TCR{alpha}°V{alpha}14Tg mice; Ref. 20) to assess whether increasing the frequency of V{alpha}14+ NKT cells would alter the antilisterial response in vivo. Lymphoid organs from these mice are enriched in invariant or "type I" V{alpha}14+ NKT cells, which can be detected using CD1d/{alpha}GC-loaded tetramers (3, 4). TCR{alpha}°V{alpha}14Tg mice harbor increased percentages and absolute numbers of CD1d-reactive T cells in the liver, spleen, and lymph nodes (Fig. 4 and data not shown) compared with wild-type mice or TCR{alpha}° littermates as previously reported (20, 34). The CD1d-reactive T cells were comprised of a major population of NK1.1+, CD4, CD8, and CD5+ T cells and a smaller fraction of NK1.1CD5+ T cells (Fig. 4 and data not shown), the latter of which could represent immature NKT cells that have recently exited the thymus (14, 35). CD1d-reactive T cells from TCR{alpha}°V{alpha}14Tg mice expressed CD122, 2B4, and DX5 markers at levels similar to their wild-type counterparts (data not shown).



View larger version (33K):
[in this window]
[in a new window]
 
FIGURE 4. Phenotype of CD1d-reactive T cells in C57BL/6, TCR{alpha}-deficient, and TCR{alpha}°V{alpha}14Tg mice. Spleen, lymph node, and hepatic lymphocytes were isolated from control C57BL/6, TCR{alpha}-deficient (TCR{alpha}°), and TCR{alpha}°V{alpha}14Tg mice and analyzed for TCR{alpha}{beta} expression and reactivity with {alpha}-GC-loaded CD1d tetramers. Region indicates percentages of tetramer+ T cells. Liver tetramer+ T cells were further analyzed for NK1.1 and CD5 expression. Percentages of NK1.1+ and NK1.1 CD5+ T cells are indicated. Representative results of six independent mice are presented.

 
We orally infected wild-type, TCR{alpha}°V{alpha}14Tg, TCR{alpha}°, and alymphoid Rag°{gamma}c° mice and evaluated the bacterial burden in the liver and spleen 7 days later. Rag°{gamma}c° mice accumulated high bacterial levels in the liver and spleen (Fig. 5A) and succumbed to disseminated infection by day 10 (Fig. 5B). In contrast, wild-type mice efficiently controlled the enteric infection with bacterial clearance from the target organs (Fig. 4A) and survived at least 8 wk (Fig. 5B). Concerning TCR{alpha}°V{alpha}14Tg and TCR{alpha}°, both types of mice could control the early infection by L. monocytogenes (Fig. 5A) and survived this infection protocol (Fig. 5B). No obvious differences were noted in terms of efficiency of the response or in the kinetics of bacterial clearance (data not shown).



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 5. TCR{alpha}°V{alpha}14Tg and TCR{alpha}° mice are resistant to enteric L. monocytogenes infection. A, Wild-type, Rag°{gamma}c°, TCR{alpha}°V{alpha}14Tg, and TCR{alpha}° mice were infected i.g. with 5 x 108 L. monocytogenes strain LO28. CFU in the liver and spleen were determined 7 days postinfection. Data represent the mean from groups of six mice, and SD values are indicated. Similar results were obtained in a second experiment. Asterisk indicates significant difference from Rag°{gamma}c° mice, p < 0.005. B, Survival of wild-type, Rag°{gamma}c°, TCR{alpha}°V{alpha}14Tg, and TCR{alpha}° mice after i.g. infection with 5 x 108 L. monocytogenes strain LO28.

 
We analyzed the serum levels of IFN-{gamma} before and during the course of infection. Wild-type mice mounted a strong systemic IFN-{gamma} response upon infection with L. monocytogenes, whereas IFN-{gamma} could not be detected in the serum from Rag°{gamma}c° mice (Table II). TCR{alpha}° mice showed reduced IFN-{gamma} levels as compared with wild-type mice, whereas TCR{alpha}°V{alpha}14Tg mice had systemic IFN-{gamma} levels comparable to those observed in control mice (Table II). These data are consistent with the potential of V{alpha}14+ NKT cells to provide an early source of IFN-{gamma} in response to enteric L. monocytogenes infection and their capacity to transactivate other cell types for enhanced IFN-{gamma} production (Ref. 16 and Table I). Nevertheless, in TCR{alpha}° mice, {gamma}{delta} T cells and/or NK cells appear sufficient to control early L. monocytogenes infection (5, 10) in the absence of V{alpha}14+ NKT cells.


View this table:
[in this window]
[in a new window]
 
Table II. Serum IFN-{gamma} levels following oral infection with L. monocytogenes

 
Purified V{alpha}14+ NKT cells provide early protection against L. monocytogenes in vivo

To directly evaluate a role for V{alpha}14+ NKT cells in early protection against enteric L. monocytogenes infection, Rag°{gamma}c° mice were adoptively transferred with highly purified invariant V{alpha}14+ NKT cells. These V{alpha}14+ NKT-reconstituted mice offer the possibility to directly test effector functions of NKT cells, since Rag°{gamma}c° mice are devoid of all lymphocytes (29). A highly purified population of CD1d-reactive V{alpha}14+ NKT cells (> 98% CD5+, NK1.1+; Fig. 6A) was isolated from TCR{alpha}°V{alpha}14Tg mice and injected i.v. into nonirradiated Rag°{gamma}c° mice. After 4 days (during which the transferred V{alpha}14+ NKT cells underwent homeostatic expansion; Ref. 36), these V{alpha}14+ NKT-reconstituted mice were infected orally with L. monocytogenes (Fig. 6A). Bacterial burdens were assessed 4 days later. Transfer of 5 x 105 purified NKT cells was able to provide almost 2 logs of protection against L. monocytogenes in the liver and spleen of alymphoid Rag°{gamma}c° mice (Fig. 6B).



View larger version (17K):
[in this window]
[in a new window]
 
FIGURE 6. Invariant V{alpha}14+ NKT cells mediate innate protection against enteric L. monocytogenes infection. A, Lymph node cells from control C57BL/6, TCR{alpha}-deficient (TCR{alpha}°), and TCR{alpha}°V{alpha}14Tg mice were analyzed for NK1.1 and CD5 expression. CD5+NK1.1+ T cells were further analyzed for TCR{alpha}{beta} expression and reactivity with {alpha}-GC-loaded CD1d tetramers. Sorted V{alpha}14+ NKT cells (98% pure) from TCR{alpha}°V{alpha}14Tg mice were adoptively transferred to Rag°{gamma}c° mice and infected i.g. with 5 x 108 L. monocytogenes strain LO28. B, CFU in the liver and spleen were determined 4 days postinfection. Data are derived from groups of five to eight mice; the mean and SD are indicated. C, Survival of wild-type, Rag°{gamma}c°, and V{alpha}14+ NKT-reconstituted mice after i.g. infection with 5 x 108 L. monocytogenes strain LO28. D, Synthesis of IFN-{gamma} by CD1d-reactive T cells in NKT-reconstituted Rag°{gamma}c° mice 3 days after L. monocytogenes infection. Bars in upper histograms indicate percentages of IFN-{gamma}-positive cells as compared with staining with isotype control Abs.

 
The reduced bacterial burden in V{alpha}14+ NKT-reconstituted mice was correlated with enhanced survival after L. monocytogenes infection. Unmanipulated Rag°{gamma}c° mice succumbed to L. monocytogenes dissemination by ~10 days, whereas adoptive transfer of 5 x 105 purified V{alpha}14+ NKT cells protected these mice for >20 days (Fig. 6C). This early protection against L. monocytogenes was associated with an increase in serum IFN-{gamma} levels at day 3 postinfection (NKT-reconstituted Rag°{gamma}c° mice: 190 ± 132 pg/ml vs Rag°{gamma}c° mice: < 25 pg/ml), and intracellular staining demonstrated that CD1d-reactive V{alpha}14+ NKT cells were producing IFN-{gamma} after L. monocytogenes infection (Fig. 6D). Under these conditions, we were unable to detect any IL-4 production from the transferred V{alpha}14+ NKT cells after exposure to L. monocytogenes (data not shown).

V{alpha}14+ NKT cells do not mediate adaptive immunity to L. monocytogenes

Having shown that V{alpha}14+ NKT cells can participate in innate immune responses, we next asked whether these cells could mediate adaptive immunity to L. monocytogenes. "Naive" (uninfected) and "immunized" (orally infected 4 wk previously with 5 x 108 L. monocytogenes) wild-type, TCR{alpha}°V{alpha}14Tg, and TCR{alpha}° mice were challenged systemically with an elevated dose (2 x 106 i.v.) of L. monocytogenes (Fig. 7). Resistance to this protocol of infection correlates with successful generation of adaptive immune responses (reviewed in Refs. 1 and 7). As expected, naive mice, irrespective of their genotype, rapidly succumbed to infection with bacterial dissemination in the liver, spleen, and brain (Fig. 6 and data not shown). In contrast, immunized wild-type mice were able to control the infection and survived the 15-day observation period (Figs. 3B and 7). Immunized TCR{alpha}° and TCR{alpha}°V{alpha}14Tg mice, however, failed to control the infection (Fig. 7), demonstrating their inability to generate an adaptive immune response to L. monocytogenes.



View larger version (12K):
[in this window]
[in a new window]
 
FIGURE 7. V{alpha}14+ NKT cells do not mediate sterilizing memory responses to L. monocytogenes. C57BL/6, TCR{alpha}°V{alpha}14Tg, and TCR{alpha}° mice were immunized by i.g. infection with 5 x 108 L. monocytogenes strain LO28 and rested 6 wk. Naive ({circ}) or immunized mice (•) were then challenged with a lethal dose of 2 x 106 L. monocytogenes strain LO28 i.v. and their survival was monitored for a period of 15 days.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Using a combination of approaches, including analysis with CD1d tetramers, V{alpha}14+ NKT cell transgenic and knockout mice and selective reconstitution of alymphoid mice with highly purified V{alpha}14+ NKT cells, we have reassessed the role of V{alpha}14+ NKT cells in the immunity against enteric infection with the intracellular bacterium L. monocytogenes. Although previous reports suggested a negative impact of NKT cells on antilisterial immunity (27, 28), we found that V{alpha}14+ NKT cells were stimulated to produce IFN-{gamma} in vivo following enteric L. monocytogenes infection and were able to provide early protection of highly susceptible alymphoid mice against L. monocytogenes. In contrast, we demonstrated that V{alpha}14+ NKT cells do not provide adaptive immunity to this pathogen under conditions of recall stimulation.

The capacity of {alpha}-GC-loaded CD1d tetramers to unambiguously identify invariant V{alpha}14+ T cells provided an essential tool for our studies. Previous reports have demonstrated the specificity of this reagent in wild-type mice and in transgenic mice bearing a functionally rearranged V{alpha}14-J{alpha}18 TCR{alpha} chain that develops increased numbers of V{alpha}14+ NKT cells (32, 34). These TCR{alpha}°V{alpha}14Tg mice provided us with the means to directly assess the functional capacity of V{alpha}14+ NKT cells to provide early protection after L. monocytogenes infection. One caveat of our experiments is whether the NKT cells derived from TCR{alpha}°V{alpha}14Tg mice faithfully represent their counterparts from wild-type mice. Previous studies have shown that CD1d-reactive NK1.1+ T cells from TCR{alpha}°V{alpha}14Tg mice have a TCR{beta} repertoire and cell surface phenotype that closely matches NK1.1+ T cells from C57BL/6 mice (34). Moreover, NKT cells from TCR{alpha}°V{alpha}14Tg mice, like their normal counterparts, have the capacity to rapidly produce cytokines (IL-4, IFN-{gamma}) following in vitro stimulation (20, 34). Thus, by several distinct criteria, the V{alpha}14+ NKT cells from TCR{alpha}°V{alpha}14Tg mice appear to faithfully represent their normal C57BL/6 counterparts.

CD1d-reactive V{alpha}14+ T cells from both C57BL/6 and TCR{alpha}°V{alpha}14Tg mice harbor a subset of NK1.1 cells. Previous studies from Benlagha et al. (14) have demonstrated that these cells in C57BL/6 mice likely represent precursors of the NK1.1+ cells. Using CD1d tetramers, these authors found that the NK1.1 subset of V{alpha}14+ T cells bore an immature phenotype and selectively produced IL-4, but not IFN-{gamma}, after stimulation. The presence of NK1.1V{alpha}14+ T cells in the spleen suggested that these precursors could exit the thymus and further differentiate into NK1.1+ IFN-{gamma} secreting mature V{alpha}14+ NKT cells in the periphery. Additional experiments showed that purified NK1.1 CD1d-reactive T cells could give rise after adoptive transfer to NK1.1+ progeny. The presence of two phenotypically and functionally distinct V{alpha}14+ T cell subsets in the periphery of mice could allow for flexibility in the ways that immune responses could be oriented.

The ability of TCR{alpha}° mice to control primary L. monocytogenes infection is consistent with the previously recognized capacity of TCR{gamma}{delta} and NK cells to participate in innate immunity against this pathogen (3, 6, 10). No difference in the bacterial burden or early survival was observed among wild-type, TCR{alpha}°, and TCR{alpha}°V{alpha}14Tg mice following enteric L. monocytogenes infection. This observation argues against any predominant regulatory role for V{alpha}14+ NKT cells in the immunity against enteric L. monocytogenes, in contrast with previous studies (27, 28) that reported an amelioration of listeriosis in mice treated with anti-CD1 mAbs. These authors deduced that the blockade of CD1 interfered with the activation of NKT cells, resulting in decreased TGF-{beta} levels and increased IFN-{gamma}, TNF-{alpha}, and IL-12 production. Since TCR{alpha}°V{alpha}14Tg mice were as resistant as TCR{alpha}° mice to primary infection, our results are incompatible with a dominant negative activity of V{alpha}14+ NKT cells during L. monocytogenes infection. Still, NKT cells could impact on L. monocytogenes infections under conditions when NK and/or {gamma}{delta} T cells are limiting.

We used adoptive transfer of V{alpha}14+ NKT cells from TCR{alpha}°V{alpha}14Tg mice to assess the capacity of these cells to confer protection against L. monocytogenes when transplanted into alymphoid Rag°{gamma}c° mice. We observed a beneficial effect of V{alpha}14+ NKT cells in this setting, which correlated with IFN-{gamma} (but not IL-4) production. It is interesting to consider our results in light of the observations that V{alpha}14+ NKT cells can produce both IFN-{gamma} and IL-4 following TCR stimulation in vitro. In contrast, V{alpha}14+ NKT cells can preferentially produce either IL-4 or IFN-{gamma} following stimulation with cytokines (37). The restricted biological activity of NKT cells after L. monocytogenes infection could indicate that these cells do not receive TCR stimulation via CD1d complexes in vivo in the setting. Recent studies by Brenner and colleagues (38) reported that Salmonella infection activated V{alpha}14+ NKT cells in a TCR- and IL-12-dependent fashion. We also have preliminary evidence that MHC-deficient Rag°{gamma}c° mice (which lack expression of CD1 molecules) reconstituted with NKT are able to resist early L. monocytogenes infection (T, Ranson and J. P. Di Santo, unpublished observations). These results would suggest that V{alpha}14+ NKT cells are recruited to respond to certain types of intracellular infections dependent on the cytokine milieu; a pro-Th1 (IL-12)-rich environment would then favor V{alpha}14+ NKT production of IFN-{gamma}. Following L. monocytogenes infection, TCR{alpha}°V{alpha}14Tg mice displayed systemic IFN-{gamma} levels comparable to those of wild-type mice and 3- to 4-fold higher levels than found in TCR{alpha}° mice. Early IFN-{gamma} production by V{alpha}14+ NKT cells therefore represents a likely antilisterial mechanism in our experiments, although direct NKT cell-mediated killing of L. monocytogenes-infected macrophages cannot be ruled out (39).

In our transfer experiments, we found that NKT cells were able to substantially reduce the bacterial burden in the liver and spleen of the Rag°{gamma}c° hosts (by almost 2 logs) after enteric L. monocytogenes infection. The level of protection afforded by the injected NKT cells is even more impressive considering the limited number of NKT cells transferred and the fact that homeostatic expansion of these cells only results in the generation of ~105 NKT cells in the liver and spleen of the recipient hosts (36). In addition, the transplanted V{alpha}14+ NKT cells might have undergone apoptosis following stimulation in vivo (40). Thus, despite being unable to completely eradicate the bacterial inoculum, NKT cells demonstrated potent antilisterial activity which resulted in protection of the reconstituted mice for at least 3 wk.

V{alpha}14+ NKT cells have been shown to "cross-talk" with other lymphocytes, including NK, B, and T cells (15, 16). In particular, it has been shown that NKT-NK cell interactions may play an important role in tumor surveillance in vivo (reviewed in Ref. 21). Our results using adoptive transfer showed that NKT cells alone provide early protection after L. monocytogenes infection. Still, functional synergy between NKT and NK cells may allow for an even better protection after infectious challenge. The use of CD1d/{alpha}-GC tetramers allowed us to directly demonstrate that V{alpha}14+ NKT cells in C57BL/6 mice respond after L. monocytogenes infection by production of IFN-{gamma}. Comparisons of C57BL/6 and J{alpha}18° mice revealed a major difference in NK cell IFN-{gamma} production after L. monocytogenes infection, consistent with V{alpha}14+ NKT cell transactivation of NK cells in vivo.

The fact that TCR{alpha}° and TCR{alpha}°V{alpha}14Tg mice did not mount functional memory responses to L. monocytogenes is consistent with previous reports demonstrating a pivotal role for cytotoxic CD8+ {alpha}{beta} T cells in the generation of antilisterial memory responses (reviewed in Refs. 1 and 7). Our observations indicate that NKT cells do not play an essential role in recall responses to L. monocytogenes. Nevertheless, NKT cells could amplify memory responses via transactivation of previously established CD8 memory T cells. The capacity for NKT cells to rapidly produce IFN-{gamma} and to potentiate its production by other lymphocytes (NK cells, {gamma}{delta} T cells, CD8 memory T cells) after L. monocytogenes infection provides an important physiological example of the important role of NKT cells as a bridge between innate and adaptive immunity.


    Acknowledgments
 
We thank Dr. D. Guy-Grand for helpful discussions. We are indebted to Pharmaceutical Research Laboratory, Kirin Brewery Company, for providing {alpha}-GC and to P. Van Endert and M. Kronenberg for help in generating CD1d tetramers.


    Disclosures
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The authors have no financial conflict of interest.


    Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Institut Pasteur, INSERM, Association pour la Recherche sur le Cancer, and Ligue National Contre le Cancer. S.B. was the recipient of a postdoctoral fellowship from the Danish Research Agency. Back

2 T.R. and S.B. contributed equally to this work. Back

3 Current address: Symphogen, DK-2800 Lyngby, Denmark. Back

4 Address correspondence and reprint requests to Dr. James P. Di Santo, Unité des Cytokines et Développement Lymphoïde, INSERM Unité 668, Institut Pasteur, 25 Rue du Docteur Roux, Cedex 15, Paris, France. E-mail address: disanto{at}pasteur.fr Back

5 Abbreviations used in this paper: Tg, transgenic; BHI, brain-heart infusion; {gamma}c, common {gamma}-chain; Tg, transgene; {alpha}-GC, {alpha}-galactosylceramide; mLN, mesenteric lymph node; i.g., intragastric. Back

Received for publication January 26, 2005. Accepted for publication April 21, 2005.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Pamer, E. G.. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.[Medline]
  2. Szalay, G., J. Hess, S. H. Kaufmann. 1995. Restricted replication of Listeria monocytogenes in a {gamma} interferon-activated murine hepatocyte line. Infect. Immun. 63: 3187-3195.[Abstract]
  3. Tripp, C. S., M. K. Gately, J. Hakimi, P. Ling, E. R. Unanue. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice: reversal by IFN-{gamma}. J. Immunol. 152: 1883-1887.[Abstract]
  4. Teixeira, H. C., S. H. Kaufmann. 1994. Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-{gamma} producers but impair resistance to Listeria monocytogenes infection. J. Immunol. 152: 1873-1883.[Abstract]
  5. Unanue, E. R.. 1997. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9: 35-43.[Medline]
  6. Bancroft, G. J., R. D. Schreiber, E. R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124: 5-24.[Medline]
  7. Harty, J. T., L. L. Lenz, M. J. Bevan. 1996. Primary and secondary immune responses to Listeria monocytogenes. Curr. Opin. Immunol. 8: 526-530.[Medline]
  8. Ladel, C. H., I. E. Flesch, J. Arnoldi, S. H. Kaufmann. 1994. Studies with MHC-deficient knockout mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J. Immunol. 153: 3116-3122.[Abstract]
  9. Sun, J. C., M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.[Abstract/Free Full Text]
  10. Mombaerts, P., J. Arnoldi, F. Russ, S. Tonegawa, S. H. Kaufmann. 1993. Different roles of {alpha}{beta} and {gamma}{delta} T cells in immunity against an intracellular bacterial pathogen. Nature 365: 53-56.[Medline]
  11. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, L. Van Kaer. 2004. NKT cells: what’s in a name?. Nat. Rev. Immunol. 4: 231-237.[Medline]
  12. Zhou, D., J. Mattner, C. Cantu, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.[Abstract/Free Full Text]
  13. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al 1997. CD1d-restricted and TCR-mediated activation of v{alpha}14 NKT cells by glycosylceramides. Science 278: 1626-1629.[Abstract/Free Full Text]
  14. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, A. Bendelac. 2002. A thymic precursor to the NK T cell lineage. Science 296: 553-555.[Abstract/Free Full Text]
  15. Kitamura, H., A. Ohta, M. Sekimoto, M. Sato, K. Iwakabe, M. Nakui, T. Yahata, H. Meng, T. Koda, S. Nishimura, et al 2000. {alpha}-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199: 37-42.[Medline]
  16. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650.[Abstract/Free Full Text]
  17. Zeng, D., D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. Garcia-Ojeda, R. Sibley, S. Strober. 1999. Bone marrow NK1.1 and NK1.1+ T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189: 1073-1081.[Abstract/Free Full Text]
  18. Kaneko, Y., M. Harada, T. Kawano, M. Yamashita, Y. Shibata, F. Gejyo, T. Nakayama, M. Taniguchi. 2000. Augmentation of V{alpha}14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191: 105-114.[Abstract/Free Full Text]
  19. Ito, K., M. Karasawa, T. Kawano, T. Akasaka, H. Koseki, Y. Akutsu, E. Kondo, S. Sekiya, K. Sekikawa, M. Harada, et al 2000. Involvement of decidual V{alpha}14 NKT cells in abortion. Proc. Natl. Acad. Sci. USA 97: 740-744.[Abstract/Free Full Text]
  20. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J. F. Bach, R. C. Monteiro. 1998. Overexpression of natural killer T cells protects V{alpha}14- J{alpha}281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188: 1831-1839.[Abstract/Free Full Text]
  21. Smyth, M. J., D. I. Godfrey, J. A. Trapani. 2001. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2: 293-299.[Medline]
  22. Park, S. H., A. Bendelac. 2000. CD1-restricted T-cell responses and microbial infection. Nature 406: 788-792.[Medline]
  23. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated V{alpha}14 natural killer T cells. J. Exp. Med. 190: 783-792.[Abstract/Free Full Text]
  24. Burdin, N., L. Brossay, M. Kronenberg. 1999. Immunization with {alpha}-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29: 2014-2025.[Medline]
  25. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, M. Tsuji. 2000. {alpha}-Galactosylceramide-activated V{alpha}14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97: 8461-8466.[Abstract/Free Full Text]
  26. Arrunategui-Correa, V., H. S. Kim. 2004. The role of CD1d in the immune response against Listeria infection. Cell. Immunol. 227: 109-120.[Medline]
  27. Emoto, M., Y. Emoto, S. H. Kaufmann. 1995. Interleukin-4-producing CD4+NK1.1+ TCR {alpha}/{beta} intermediate liver lymphocytes are down-regulated by Listeria monocytogenes. Eur. J. Immunol. 25: 3321-3325.[Medline]
  28. Szalay, G., C. H. Ladel, C. Blum, L. Brossay, M. Kronenberg, S. H. Kaufmann. 1999. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-{beta}2 and Th1 cytokines and ameliorates listeriosis in mice. J. Immunol. 162: 6955-6958.[Abstract/Free Full Text]
  29. Colucci, F., C. Soudais, E. Rosmaraki, L. Vanes, V. L. Tybulewicz, J. P. Di Santo. 1999. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162: 2761-2765.[Abstract/Free Full Text]
  30. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, M. Taniguchi. 1997. Requirement for V{alpha}14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.[Abstract/Free Full Text]
  31. Gaillot, O., E. Pellegrini, S. Bregenholt, S. Nair, P. Berche. 2000. The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes. Mol. Microbiol. 35: 1286-1294.[Medline]
  32. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.[Abstract/Free Full Text]
  33. Bregenholt, S., P. Berche, F. Brombacher, J. P. Di Santo. 2001. Conventional {alpha}{beta} T cells are sufficient for innate and adaptive immunity against enteric Listeria monocytogenes. J. Immunol. 166: 1871-1876.[Abstract/Free Full Text]
  34. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, A. Bendelac. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191: 1895-1903.[Abstract/Free Full Text]
  35. Pellicci, D. G., K. J. Hammond, A. P. Uldrich, A. G. Baxter, M. J. Smyth, D. I. Godfrey. 2002. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1CD4+ CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.[Abstract/Free Full Text]
  36. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, J. P. Di Santo. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100: 2663-2668.[Abstract/Free Full Text]
  37. Leite-De-Moraes, M. C., A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, A. Herbelin. 2001. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J. Immunol. 166: 945-951.[Abstract/Free Full Text]
  38. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4: 1230-1237.[Medline]
  39. Emoto, M., Y. Emoto, S. H. Kaufmann. 1997. TCR-mediated target cell lysis by CD4+NK1+ liver T lymphocytes. Int. Immunol. 9: 563-571.[Abstract/Free Full Text]
  40. Eberl, G., H. R. MacDonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3{epsilon}- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9: 345-355.[Medline]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H.-J. Choi, H. Xu, Y. Geng, A. Colmone, H. Cho, and C.-R. Wang
Bacterial infection alters the kinetics and function of iNKT cell responses
J. Leukoc. Biol., December 1, 2008; 84(6): 1462 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. H. F. Pedra, J. Mattner, J. Tao, S. M. Kerfoot, R. J. Davis, R. A. Flavell, P. W. Askenase, Z. Yin, and E. Fikrig
c-Jun NH2-Terminal Kinase 2 Inhibits Gamma Interferon Production during Anaplasma phagocytophilum Infection
Infect. Immun., January 1, 2008; 76(1): 308 - 316.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
G. Wingender and M. Kronenberg
Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G1 - G8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Zeissig, A. Kaser, S. K. Dougan, E. E. S. Nieuwenhuis, and R. S. Blumberg
Role of NKT Cells in the Digestive System. III. Role of NKT cells in intestinal immunity
Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1101 - G1105.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M.-L. Michel, A. C. Keller, C. Paget, M. Fujio, F. Trottein, P. B. Savage, C.-H. Wong, E. Schneider, M. Dy, and M. C. Leite-de-Moraes
Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia
J. Exp. Med., May 14, 2007; 204(5): 995 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Mallevaey, J. Fontaine, L. Breuilh, C. Paget, A. Castro-Keller, C. Vendeville, M. Capron, M. Leite-de-Moraes, F. Trottein, and C. Faveeuw
Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine Schistosomiasis
Infect. Immun., May 1, 2007; 75(5): 2171 - 2180.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Raghuraman, Y. Geng, and C.-R. Wang
IFN-beta-Mediated Up-Regulation of CD1d in Bacteria-Infected APCs
J. Immunol., December 1, 2006; 177(11): 7841 - 7848.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Emoto, I. Yoshizawa, Y. Emoto, M. Miamoto, R. Hurwitz, and S. H. E. Kaufmann
Rapid Development of a Gamma Interferon-Secreting Glycolipid/CD1d-Specific V{alpha}14+ NK1.1- T-Cell Subset after Bacterial Infection.
Infect. Immun., October 1, 2006; 74(10): 5903 - 5913.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Xu, T. Chun, H.-J. Choi, B. Wang, and C.-R. Wang
Impaired response to Listeria in H2-M3-deficient mice reveals a nonredundant role of MHC class Ib-specific T cells in host defense
J. Exp. Med., February 21, 2006; 203(2): 449 - 459.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranson, T.
Right arrow Articles by Di Santo, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranson, T.
Right arrow Articles by Di Santo, J. P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS